Basic Information
ID: ALA4685023
Type: Binding
Description: Inhibition of full length human PKAcalpha assessed as remaining activity at 1 uM using LRRASLG as substrate incubated for 40 mins by scintillation counting method relative to control
Format: BAO_0000357
Organism: Homo sapiens
Target: cAMP-dependent protein kinase alpha-catalytic subunit(ALA4101)
Document: ALA4680191
Inhibition of full length human PKAcalpha assessed as remaining activity at 1 uM using LRRASLG as substrate incubated for 40 mins by scintillation counting method relative to control: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4685023
Activity
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 541.17 | 4.54 | 4.54 |
| 570.16 | 3.81 | 3.81 |
| 484.07 | 4.26 | 4.26 |
| 524.13 | 5.19 | 5.19 |
| 557.56 | 3.87 | 3.87 |
| 500.07 | 3.85 | 3.85 |
| 498.10 | 4.65 | 4.65 |
| 467.61 | 3.75 | 3.75 |
| 553.18 | 4.69 | 4.69 |
| 527.14 | 4.15 | 4.15 |
| 539.15 | 4.30 | 4.30 |
| 510.11 | 4.80 | 4.80 |
| 513.11 | 3.76 | 3.76 |
| 541.17 | 4.54 | 4.54 |
| 527.14 | 4.15 | 4.15 |
| 492.69 | 3.42 | 3.42 |
| 479.65 | 3.62 | 3.62 |
| 498.10 | 4.66 | 4.66 |
| 508.69 | 3.12 | 3.12 |
| 539.15 | 4.30 | 4.30 |
| 484.07 | 4.26 | 4.26 |
| 528.52 | 4.37 | 4.37 |
| 499.08 | 3.37 | 3.37 |
| 589.21 | 5.33 | 5.33 |
| 470.04 | 3.88 | 3.88 |
| 496.66 | 3.25 | 3.25 |
| 513.11 | 3.76 | 3.76 |